Publikationen, an denen er mitarbeitet Eva Solá Izquierdo (24)

2024

  1. Molecular circadian clock disruption in the leukocytes of individuals with type 2 diabetes and overweight, and its relationship with leukocyte–endothelial interactions

    Diabetologia

2023

  1. Effects of GLP-1 receptor agonists on mitochondrial function, inflammatory markers and leukocyte-endothelium interactions in type 2 diabetes

    Redox biology, Vol. 66, pp. 102849

2022

  1. The Role of Mitochondrial Dynamic Dysfunction in Age-Associated Type 2 Diabetes

    World Journal of Men's Health, Vol. 40

2021

  1. Does empagliflozin modulate leukocyte–endothelium interactions, oxidative stress, and inflammation in type 2 diabetes?

    Antioxidants, Vol. 10, Núm. 8

2019

  1. Does Glycemic Control Modulate the Impairment of NLRP3 Inflammasome Activation in Type 2 Diabetes?

    Antioxidants and Redox Signaling, Vol. 30, Núm. 2, pp. 232-240

  2. Relationship between oxidative stress, ER stress, and inflammation in type 2 diabetes: The battle continues

    Journal of Clinical Medicine, Vol. 8, Núm. 9

  3. The mitochondrial antioxidant SS-31 modulates oxidative stress, endoplasmic reticulum stress, and autophagy in type 2 diabetes

    Journal of Clinical Medicine, Vol. 8, Núm. 9

2018

  1. Does Metformin Modulate Endoplasmic Reticulum Stress and Autophagy in Type 2 Diabetic Peripheral Blood Mononuclear Cells?

    Antioxidants and Redox Signaling, Vol. 28, Núm. 17, pp. 1562-1569

  2. Mitochondrial DNA haplogroup JT is related to impaired glycaemic control and renal function in type 2 diabetic patients

    Journal of Clinical Medicine, Vol. 7, Núm. 8

2016

  1. Atherosclerosis, Mitochondrial Dysfunction and Oxidative Stress: Mitochondria-Targeted Anti-oxidants as Potential Therapy

    Frontiers in Medicinal Chemistry (Bentham Science Publishers), pp. 96-135

  2. Role of oxidative stress and mitochondrial dysfunction in skeletal muscle in type 2 diabetic patients

    Current Pharmaceutical Design, Vol. 22, Núm. 18, pp. 2650-2656

2015

  1. The consumption of a bread enriched with dietary fibre and L-carnitine improves glucose homoeostasis and insulin sensitivity in patients with metabolic syndrome

    Journal of Cereal Science, Vol. 64, pp. 159-167

2014

  1. Circulating irisin levels are not correlated with BMI, age, and other biological parameters in obese and diabetic patients

    Endocrine, Vol. 46, Núm. 3, pp. 674-677

2013

  1. Association of serum retinol binding protein 4 with atherogenic dyslipidemia in morbid obese patients

    PLoS ONE, Vol. 8, Núm. 11

  2. Human leukocyte/endothelial cell interactions and mitochondrial dysfunction in type 2 diabetic patients and their association with silent myocardial ischemia

    Diabetes Care, Vol. 36, Núm. 6, pp. 1695-1702

  3. Relation between lipoprotein subfractions and TSH levels in the cardiovascular risk among women with subclinical hypothyroidism

    Clinical Endocrinology, Vol. 78, Núm. 5, pp. 777-782

2012

  1. Effect of weight loss on C3 and C4 components of complement in obese patients

    European Journal of Clinical Investigation, Vol. 42, Núm. 5, pp. 503-509

  2. Estudio de las subfracciones lipoproteicas tras el tratamiento de simvastatina y ezetimiba, en monoterapia o combinado, en pacientes hiperlipidémicos

    Clinica e Investigacion en Arteriosclerosis, Vol. 24, Núm. 5, pp. 217-225

2011

  1. Low intestinal cholesterol absorption is associated with a reduced efficacy of phytosterol esters as hypolipemic agents in patients with metabolic syndrome

    Clinical Nutrition, Vol. 30, Núm. 5, pp. 604-609

  2. Mitochondrial complex i impairment in leukocytes from type 2 diabetic patients

    Free Radical Biology and Medicine, Vol. 50, Núm. 10, pp. 1215-1221